Construction of a Liver Cancer Prognostic Model Based on Interferon-Gamma-Related Genes for Revealing the Immune Landscape
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study identifies interferon-gamma (IFN-γ)-related genes to develop a 10-gene prognostic model for liver cancer, revealing subtypes with distinct survival and immune profiles, aiding immunotherapy decisions.
Area Of Science
- Oncology
- Immunology
- Genetics
Background
- Interferon-gamma (IFN-γ) has anti-tumor properties, but its prognostic role in liver cancer via related genes is not well-established.
- Existing research lacks a comprehensive analysis of IFN-γ-related gene expression and its impact on liver cancer prognosis.
Purpose Of The Study
- To identify differentially expressed IFN-γ-related genes in liver cancer.
- To develop and validate a prognostic model based on these genes.
- To explore immune characteristics and drug sensitivity associated with identified liver cancer subtypes.
Main Methods
- Utilized GO/KEGG databases and literature to identify IFN-γ-related differentially expressed genes (DEGs).
- Clustered liver cancer patients based on DEGs and constructed a prognostic model using intersection genes.
- Validated the model using GEO datasets and performed regression analysis and nomogram construction.
- Conducted immune-related analysis and investigated gene-drug sensitivity correlations.
Main Results
- Identified significant differential expression of IFN-γ-related genes between liver cancer and control groups.
- Classified liver cancer patients into two subtypes with significant survival differences.
- Developed a 10-gene prognostic model demonstrating good predictive performance and independent prognostic value.
- Observed higher immune infiltration and favorable immunotherapy indicators in the 'L-group' subtype.
- Identified correlations between model genes and specific drug sensitivities.
Conclusions
- A 10-gene prognostic model for liver cancer was successfully constructed, serving as an independent prognostic factor.
- Liver cancer subtypes exhibit distinct survival outcomes and immune infiltration levels.
- The 'L-group' subtype shows greater suitability for immunotherapy, offering valuable prognostic insights.
- This study provides critical information for liver cancer prognosis and potential therapeutic strategies.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
